Atlas FDA

Saluda Medical Evoke SCS System

FDA premarket approval P190002/S005 · decided 2022-07-06

Approval details

PMA number
P190002
Supplement
S005
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Saluda Medical Evoke SCS System
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Saluda Medical Pty, Ltd.
Date received
2022-04-08
Decision date
2022-07-06
Days to decision
89 days
Decision code
APPR
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Atarmon
Statement
Approval for design changes to the lead and stylet used with the Evoke Spinal Cord Stimulation (SCS) System, including decreasing the stylet length by 14mm and removing the epoxy material surrounding the non-active band at the proximal end of the lead.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.